Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Nails can reveal important health information about skin and body conditions.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

No treatment fully prevents hair loss from chemotherapy yet.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.